Obesity and Diabetes
Salix Receives FDA Marketing APPROVAL FOR Metozolv ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Published in Law and Health Weekly, September 26th, 2009
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short-term therapy (4-12 weeks) for adults with symptomatic documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy1.
"METOZOLV ODT is the first available treatment for both diabetic gastroparesis and symptomatic documented GERD that offers physicians and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago - AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' to Cong. Hare - Advanced Micro-Fabrication Equipment Inc.
Advanced Micro-Fabrication Equipment, Inc Prevails in Patent Infringement Suit Filed Against the Company by Lam Research in Taiwan - Aetna
Aetna and the Aetna Foundation Sponsor Health Affairs Issue Offering Solutions to Address Rising Health Care Costs - Aging
Research on aging published by L.H. Plawecki et al - American Medical Association
AMA Reaction to President Obama's Address on Health-System Reform - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
